Lung cancer Board decisions

The Board denied service connection for lung cancer and remanded the claims for sleep apnea and bilateral hearing loss for further development.

The Board granted service connection for lung cancer and cause of death, but remanded the claim for chronic obstructive pulmonary disease (COPD).

The Board remands the claim for service connection of the Veteran's cause of death, which was acute hypoxic respiratory failure due to stage IV lung cancer, to obtain a medical opinion regarding the relationship between the Veteran's service and his cause of death.

The Board denied service connection for lung cancer and brain cancer, as well as a total disability rating based on individual unemployability (TDIU) for accrued benefits purposes.

The Board denied service connection for lung cancer, finding no evidence that the Veteran's lung cancer was related to his in-service exposure to depleted uranium or any other in-service injury or disease.

The Board denied an initial rating in excess of 100 percent for lung cancer but granted special monthly compensation (SMC) based on the need for aid and attendance, effective December 7, 2022.

The appeal of service connection for lung cancer with COPD and asthma is dismissed as the benefit sought on appeal has been fully granted.

The veteran withdrew the appeals for service connection for adenocarcinoma of lung and metastatic thoracic spinal tumor, thus they are dismissed.

The Board denied the Veteran's request for an earlier effective date for service connection for lung cancer and special monthly compensation, as the evidence did not support a claim under the PACT Act or other liberalizing laws.

The Board denied service connection for gastrointestinal cancer other than esophageal cancer and stomach cancer, brain cancer, and prostate cancer. The issues of entitlement to service connection for esophageal cancer, metastatic esophageal cancer, lung cancer, stomach cancer, and liver cancer were remanded.

The appeal regarding the proposed reductions in ratings for prostate cancer and lung cancer, as well as the proposal to discontinue special monthly compensation, was dismissed due to lack of a final adjudicative determination.

The Board remands the claims for service connection and TDIU due to a pre-decisional duty to assist error regarding SSA records.

The Board denied service connection for multiple conditions, including radical cystectomy residuals with colonic pouch, ventral hernia, hypertension, and others, as the evidence did not corroborate the Veteran's reported exposure to Agent Orange or asbestos during service.

The appeal for service connection for a right hand disability, hypertension, and lung cancer was dismissed due to improper substitution of the claimant.

The Board granted service connection for lung cancer, considering the Veteran's presumed exposure to contaminated water at Camp Lejeune during his active duty for training.

The Board grants an earlier effective date of March 24, 2023, for the awards of service connection for lung cancer, kidney cancer, and liver cancer.

The Board has remanded the claim for service connection for lung cancer due to conflicting information regarding the Veteran's toxic exposure risk activity (TERA) and will require further development.

The Board remands the claim for service connection for lung cancer due to a pre-existing error in not providing the Veteran with a development letter regarding evidence needed to develop his lung cancer claim as it related to chemical exposure, such as polychlorinated biphenyls and Agent Orange.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board remands the claims for service connection for lung cancer and brain cancer as secondary to lung cancer due to an inadequate VA opinion.